Mylan Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS
MYLAN LABS has sixty-five approved drugs.
There are nine tentative approvals on MYLAN LABS drugs.
Drugs and US Patents for Mylan Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Labs Ltd | ESMOLOL HYDROCHLORIDE | esmolol hydrochloride | INJECTABLE;INJECTION | 206608-002 | Jun 8, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Labs Ltd | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | INJECTABLE;INJECTION | 075375-001 | Sep 30, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Mylan Labs Ltd | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | INJECTABLE;INJECTION | 210710-001 | Oct 25, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Labs Ltd | IRON SUCROSE | iron sucrose | INJECTABLE;INTRAVENOUS | 212559-002 | Aug 8, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

